InfuSystem Holdings, Inc. (NYSE:INFU) Director Purchases $23,560.00 in Stock

by · The Cerbat Gem

InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) Director Kenneth D. Eichenbaum acquired 4,000 shares of the company’s stock in a transaction dated Monday, September 23rd. The shares were purchased at an average price of $5.89 per share, with a total value of $23,560.00. Following the completion of the acquisition, the director now owns 4,000 shares in the company, valued at $23,560. The purchase was disclosed in a filing with the SEC, which is available at this link.

InfuSystem Stock Up 2.9 %

Shares of NYSE INFU opened at $6.75 on Friday. The company has a quick ratio of 1.64, a current ratio of 2.07 and a debt-to-equity ratio of 0.64. InfuSystem Holdings, Inc. has a 1-year low of $5.74 and a 1-year high of $10.99. The stock has a market capitalization of $143.74 million, a PE ratio of -675,000.00 and a beta of 1.46.

InfuSystem (NYSE:INFU – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). InfuSystem had a net margin of 0.28% and a return on equity of 0.70%. The firm had revenue of $33.70 million during the quarter.

Institutional Investors Weigh In On InfuSystem

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Squarepoint Ops LLC acquired a new stake in shares of InfuSystem during the second quarter valued at about $230,000. Marshall Wace LLP acquired a new position in shares of InfuSystem in the second quarter worth about $131,000. First Eagle Investment Management LLC boosted its holdings in InfuSystem by 10.0% in the second quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock valued at $4,549,000 after purchasing an additional 60,813 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in InfuSystem by 52.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock valued at $178,000 after purchasing an additional 8,917 shares in the last quarter. Finally, Perritt Capital Management Inc increased its holdings in InfuSystem by 169.4% during the 2nd quarter. Perritt Capital Management Inc now owns 38,500 shares of the company’s stock worth $263,000 after purchasing an additional 24,207 shares during the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

Analysts Set New Price Targets

INFU has been the topic of several research reports. B. Riley assumed coverage on shares of InfuSystem in a report on Thursday. They issued a “buy” rating and a $13.00 price target on the stock. StockNews.com lowered shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Saturday.

View Our Latest Report on INFU

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

See Also